InvestorsHub Logo
Followers 34
Posts 2651
Boards Moderated 0
Alias Born 10/28/2013

Re: None

Thursday, 02/06/2014 10:57:06 AM

Thursday, February 06, 2014 10:57:06 AM

Post# of 730793
The PR Quote on 6 to 8 Weeks for the Review:

Oh well... looks like Ms. Linda Powers, CEO, Northwest Biotherapeutics did give a 6 to 8 week estimate for the review period, for this specific review, not as a general statement about typical reviews periods. Still... I am not that concerned.

"Due to the work involved in auditing and preparing the data, and conducting the review, it is anticipated that the DMC may complete its evaluation and recommendation approximately six to eight weeks from now."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News